FOUNDED IN 1859 BY QUEEN EMMA AND KING KAMEHAMEHA IV
The Research Business Office (RBO) provides services to investigators in various scopes, some of which are: trial agreement and budget development & execution; and fiscal and administrative support of Industry-Sponsored studies.
The following are The Queen’s Medical Center’s start-up and ongoing fees for clinical trials. Inclusive of overhead, final fees are subject to contract negotiation. All start-up fees are assessed independent of IRB approval or subject enrollment and are non-refundable.
Please note that in addition to the business fees, your study will also occur IRB related fees. All fees are subject to change.
RE: DECLARATION OF PROCUREMENT STANDARDS
The Queen’s Medical Center (QMC) hereby elects to utilize the grace period established in the Office of Management & Budget Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards; final Rule – 2 CFR Chapter I, Chapter II, Part 200, et al. also known as the Uniform Guidance (UG) for July 1, 2015 (FY 16) and continue use of Circular A-110.
Excerpt from § 200.110 (a): “For the procurement standards in §§ 200.317 – 200.326, non-Federal entities may continue to comply with the procurement standards in previous OMB guidance (superseded by this part as described in § 200.104) for two additional fiscal years after this part goes into effect. If a non-Federal entity chooses to use the previous procurement standards for two additional fiscal years before adopting the procurement standards in this part, the non-Federal entity must document this decision in their internal procurement policies.”
In the meantime, QMC shall modify and develop procurement procedures to become consistent with the Uniform Guidance. QMC shall be in compliance with the UG effective July 1, 2018 (FY 19).